this stock is wierd...no movment at all...not on good news or bad...whats wrong with it..the partnership with teva imho is good,if custirsen will work it will be a major breakthrough in chimotheraphy.. but the stock is stack... anyone???
Hi Microon. Ignore some people on this board who hate ISIS and ASO drugs. TEVA is a great partner for OGXI. It is hungry for development of its lead drugs and wishes to build a branded oncology drug division around OGXI. Wait for a year for accrual of 011 in prostate to end, then report on its success by end of 2012. If 011 or custirsen is approved, then my view is TEVA buys the pipeline of OGXI.